Shanghai Fosun Pharmaceutical (600196) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist

24.74
-0.24-0.96%

Trading Mar 5 13:38 CST

66.09BMarket Cap31.28P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Shanghai Fosun Pharma - Clinical Trial of 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine Got Approval From China's Nmpa
ReutersMar 4 05:03 ET
FOSUN PHARMA (600196.SH): The controlling subsidiary has received approval for vaccine clinical trials.
On March 4th, Glodon reported that FOSUN PHARMA (600196.SH) announced that its holding subsidiary FOSUN ANTIGEN (Chengdu) Pharmaceutical Co., Ltd. (hereinafter referred to as "FOSUN ANTIGEN") recently received approval from the National Medical Products Administration for the clinical trial of the 24-valent pneumococcal polysaccharide conjugate vaccine (Registration Classification: Preventive Biological Products Category 1.4; hereinafter referred to as "24-valent pneumococcal vaccine" or "the vaccine"). FOSUN ANTIGEN plans to conduct Phase I clinical trials of the vaccine in mainland China (excluding Hong Kong, Macao, and Taiwan) once conditions are met. This vaccine is part of the Group (that is, the Company and its holding subsidiaries).
Gelonghui FinanceMar 4 03:58 ET
The bull market for Hong Kong stocks has begun; how to identify the certainty of value growth?
At present, the technical bull market in the Hong Kong stock market is becoming the focus of attention for global investors.
Gelonghui FinanceMar 3 19:44 ET
Raziel and Fosun Pharma (by JuveStar an Affiliate Company of Fosun Pharma) Initiate Phase 3 Registration Trial in China for Submental Fat Reduction ("Double Chin")
PR NewswireMar 3 09:00 ET
Fosun Pharmaceutical Secures Clinical Trial Approval for Colorectal Cancer Treatment
MT NewswiresFeb 27 23:07 ET
Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Investors Are Sitting on a Loss of 39% If They Invested Three Years Ago
Simply Wall StFeb 27 19:58 ET

Comments

Spinee

Jun 24, 2024 21:45

HSI Opens Up 60 pts; LI AUTO & NIO Advance, as HENLIUS Rockets 21%

Hong Kong stocks opened higher in the morning. $Hang Seng Index (800000.HK)$opened 60 points or 0.3% higher at 18,088. $Hang Seng China Enterprises Index (800100.HK)$ opened 22 points or 0.3% higher at 6,463. $Hang Seng TECH Index (800700.HK)$ opened 11 points or 0.3% higher at 3,689.
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...

Spinee

Apr 25, 2023 11:34

HSI Slides 342 Pts; Techs & Pharmas Gloom

$Hang Seng Index (800000.HK)$ concluded the day at 19,617, down 342 pts or 1.7%. $Hang Seng China Enterprises Index (800100.HK)$ sagged 131 pts or 2% to 6,601. $Hang Seng TECH Index (800700.HK)$ faded 137 pts or 3.5% to 3,824. The turnover aggregated $106.657 billion.
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...

Senorita Earnings

Mar 1, 2023 23:54

Columns Expert Meeting Minutes | Seven Development Trends of the China Medical Aesthetics Industry

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...

Spinee

Dec 14, 2022 00:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $FOSUN PHARMA (02196.HK)$ shares were opened 12% higher to 29 yuan.
$Pfizer (PFE.US)$ $AIM VACCINE (06660.HK)$

Spinee

Dec 6, 2022 21:36

In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:

First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates;
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...